Literature DB >> 2171186

Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.

L Gradoville1, E Grogan, N Taylor, G Miller.   

Abstract

Lymphoid cell lines were established which stably carry the Epstein-Barr viral (EBV) BZLF1 gene on an extrachromosomal plasmid. These lines, which spontaneously synthesize the BZLF1 gene product, ZEBRA, were examined for expression of EBV genes which were activated by ZEBRA. Cell lines which acquired oriP plasmids without BZLF1 served as controls. The extent of activation differed among derivatives of four cell lines. X50-7 cells, which harbor a standard latent EBV, could be induced by ZEBRA to produce transforming virus; a cellular subclone of this line was induced to express EBV late antigens but did not release transforming virus. In two other cell lines, Raji and ER, ZEBRA activated only a group of early antigens. Using immunofluorescence and immunoblotting with monoclonal antibodies and Northern analysis five EBV early genes were shown to be induced in cells stably transformed by oriP/BZLF1 plasmids. ZEBRA itself was activated; thus BZLF1 is autostimulatory. Four other activated genes were components of the diffuse (EA-D) and restricted (EA-R) early antigens (BMRF1, BMLF1, BHRF1, and BORF2). Stable cell lines with extrachromosomal BZLF1 expression vectors will ultimately be useful in a variety of experiments designed to study regulation of this gene, to analyze the effects of mutations on ZEBRA protein function, and to define the full spectrum of viral and cellular genes which are activated by and interact with the ZEBRA protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171186     DOI: 10.1016/0042-6822(90)90331-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.

Authors:  N Taylor; E Flemington; J L Kolman; R P Baumann; S H Speck; G Miller
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.

Authors:  R Orlowski; G Miller
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.

Authors:  J L Kolman; N Taylor; L Gradoville; J Countryman; G Miller
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas.

Authors:  J van Gorp; A Brink; J J Oudejans; A J van den Brule; J G van den Tweel; N M Jiwa; P C de Bruin; C J Meijer
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

5.  Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments.

Authors:  Richard Park; Lee Heston; Duane Shedd; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2008-10-19       Impact factor: 3.616

Review 6.  Nanotechnology Frontiers in γ-Herpesviruses Treatments.

Authors:  Marisa Granato
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.